Orchard raises $110M to bring gene therapy to market – FierceBiotech
FierceBiotech |
Orchard raises $110M to bring gene therapy to market
FierceBiotech Orchard surfaced in May 2016, at which time it had $33 million in venture funding, leaders who worked on GlaxoSmithKline's ADA-SCID gene therapy Strimvelis and a clinical-phase rival to the Big Pharma's product. Now, Orchard's treatment for ADA-SCID … Gene therapy developer Orchard Therapeutics raises $110 mln |
